These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
157 related items for PubMed ID: 12023034
21. Matrix metalloproteinase expression and function during fin regeneration in zebrafish: analysis of MT1-MMP, MMP2 and TIMP2. Bai S, Thummel R, Godwin AR, Nagase H, Itoh Y, Li L, Evans R, McDermott J, Seiki M, Sarras MP. Matrix Biol; 2005 Jun; 24(4):247-60. PubMed ID: 15935631 [Abstract] [Full Text] [Related]
22. Green tea polyphenol (-)-epigallocatechin 3-gallate inhibits MMP-2 secretion and MT1-MMP-driven migration in glioblastoma cells. Annabi B, Lachambre MP, Bousquet-Gagnon N, Page M, Gingras D, Beliveau R. Biochim Biophys Acta; 2002 Jan 30; 1542(1-3):209-20. PubMed ID: 11853893 [Abstract] [Full Text] [Related]
23. Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes. Baumann P, Zigrino P, Mauch C, Breitkreutz D, Nischt R. Br J Cancer; 2000 Nov 30; 83(10):1387-93. PubMed ID: 11044366 [Abstract] [Full Text] [Related]
24. Membrane type 1 matrix metalloproteinase and gelatinase A synergistically degrade type 1 collagen in a cell model. Atkinson SJ, Patterson ML, Butler MJ, Murphy G. FEBS Lett; 2001 Mar 02; 491(3):222-6. PubMed ID: 11240131 [Abstract] [Full Text] [Related]
25. Interaction between tissue inhibitor of metalloproteinases-2 and progelatinase A: immunoreactivity analyses. Fujimoto N, Ward RV, Shinya T, Iwata K, Yamashita K, Hayakawa T. Biochem J; 1996 Feb 01; 313 ( Pt 3)(Pt 3):827-33. PubMed ID: 8611162 [Abstract] [Full Text] [Related]
26. Proteolytic action of kallikrein-related peptidase 7 produces unique active matrix metalloproteinase-9 lacking the C-terminal hemopexin domains. Ramani VC, Kaushal GP, Haun RS. Biochim Biophys Acta; 2011 Aug 01; 1813(8):1525-31. PubMed ID: 21616098 [Abstract] [Full Text] [Related]
28. Suppression of membrane-type 1 matrix metalloproteinase (MMP)-mediated MMP-2 activation and tumor invasion by testican 3 and its splicing variant gene product, N-Tes. Nakada M, Yamada A, Takino T, Miyamori H, Takahashi T, Yamashita J, Sato H. Cancer Res; 2001 Dec 15; 61(24):8896-902. PubMed ID: 11751414 [Abstract] [Full Text] [Related]
32. Role of the hemopexin domain of matrix metalloproteinases in cell migration. Dufour A, Sampson NS, Zucker S, Cao J. J Cell Physiol; 2008 Dec 15; 217(3):643-51. PubMed ID: 18636552 [Abstract] [Full Text] [Related]
33. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma. Nakada M, Kita D, Futami K, Yamashita J, Fujimoto N, Sato H, Okada Y. J Neurosurg; 2001 Mar 15; 94(3):464-73. PubMed ID: 11235952 [Abstract] [Full Text] [Related]
36. Cell-based evidence for aminopeptidase N/CD13 inhibitor actinonin targeting of MT1-MMP-mediated proMMP-2 activation. Sina A, Lord-Dufour S, Annabi B. Cancer Lett; 2009 Jul 08; 279(2):171-6. PubMed ID: 19264392 [Abstract] [Full Text] [Related]
37. Cell surface activation of progelatinase A (proMMP-2) and cell migration. Nagase H. Cell Res; 1998 Sep 08; 8(3):179-86. PubMed ID: 9791731 [Abstract] [Full Text] [Related]
38. Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes. Toth M, Chvyrkova I, Bernardo MM, Hernandez-Barrantes S, Fridman R. Biochem Biophys Res Commun; 2003 Aug 22; 308(2):386-95. PubMed ID: 12901881 [Abstract] [Full Text] [Related]